Search Results 1541-1550 of 16205 for alt

  1. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  2. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  3. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  4. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  5. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

    Patients with known Gilbert disease who have serum bilirubin level ≤ 3 x ULN may be enrolled. AST and ALT ≤ 3.0 x ULN; Alkaline phosphatase ≤ 2.5 x ULN ...

  6. Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) - Mayo Clinic

    Bilirubin > 1.5 x Upper Limit of Normal (ULN); AST and/or ALT > 2.5 x ULN; and; Serum creatinine > 1.5 x ULN. History of significant cardiovascular disease ...

  7. Liver transplant - Doctors & Departments - Mayo Clinic

    Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

  8. A Study to Assess the Effectiveness and Safety of Durvalumab Alone or Combined with Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment - Mayo Clinic

    Aspartate aminotransferase (AST) and ALT ≤ 5 × ULN;; Albumin ≥ 2.8 g/dL;; International normalized ratio ≤ 1.6 (for patients receiving Warfarin, please ...

  9. Study of BIIB092 in Participants With Progressive Supranuclear Palsy - Mayo Clinic

    Total bilirubin, alanine aminotransferase (ALT), or aspartate aminotransferase (AST) greater than 2 times the upper limit of normal (ULN), confirmed by repeat.

  10. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

    Alanine aminotransferase (ALT)/aspartate aminotransferase (AST) ≤2.5 x ULN (≤5 × ULN for patients with known hepatic metastases). 11. Adequate renal ...